Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-002650
Filing Date
2025-08-06
Accepted
2025-08-06 07:01:16
Documents
64
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2533518.htm   iXBRL 6-K 15625
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 148615
3 EXHIBIT 99.2 exhibit_99-2.htm   iXBRL EX-99.2 777847
4 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 10834
10 GRAPHIC image0.jpg GRAPHIC 1051
11 GRAPHIC image00001.jpg GRAPHIC 425524
  Complete submission text file 0001178913-25-002650.txt   5568271

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cgen-20250630.xsd EX-101.SCH 47332
6 XBRL CALCULATION FILE cgen-20250630_cal.xml EX-101.CAL 38462
7 XBRL DEFINITION FILE cgen-20250630_def.xml EX-101.DEF 136958
8 XBRL LABEL FILE cgen-20250630_lab.xml EX-101.LAB 537001
9 XBRL PRESENTATION FILE cgen-20250630_pre.xml EX-101.PRE 252767
66 EXTRACTED XBRL INSTANCE DOCUMENT zk2533518_htm.xml XML 710868
Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30902 | Film No.: 251187380
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)